The three major A-share stock indexes collectively pulled up in early trading and the Shanghai Composite Index rose 0.82% in half a day. Most industry sectors were in the red, with the pharmaceutical sector leading the gains, and related stocks such as Yabao Pharmaceutical, Wantai Biotech, Ganli Pharmaceuticals, etc.
The pharmaceutical sector was the top gainer. Northbound funds actively entered the market, with net purchases exceeding 4 billion yuan in early Trading. Central Huijin issued an announcement stating that it fully recognized the current allocation value of the A- share market and had recently expanded the scope of holdings.